BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10974580)

  • 1. Leukocytoclastic vasculitis complicating Klebsiella pneumoniae bacteremia.
    Lum PN; Woo PC; Wong SS; Yuen K
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):275-7. PubMed ID: 10974580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klebsiella pneumoniae and leukocytoclastic vasculitis.
    Lloret P; Redondo P; Molano E
    Lancet; 2002 Oct; 360(9339):1062. PubMed ID: 12383983
    [No Abstract]   [Full Text] [Related]  

  • 3. Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
    Chang EK; Kao KL; Tsai MS; Yang CJ; Huang YT; Liu CY; Liao CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):684-91. PubMed ID: 26510516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klebsiella pneumoniae-associated septic pulmonary emboli in a healthy child.
    Kano Z; Onoyama S; Tsuji M; Tezuka J; Furuno K
    Pediatr Int; 2018 Jul; 60(7):663-665. PubMed ID: 29923312
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem.
    Falagas ME; Siempos II; Tsakoumis I
    Scand J Infect Dis; 2006; 38(9):807-10. PubMed ID: 16938737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
    Maherault AC; Nordmann P; Therby A; Pangon B
    Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
    [No Abstract]   [Full Text] [Related]  

  • 9. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
    Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
    J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
    [No Abstract]   [Full Text] [Related]  

  • 10. A 68-year-old type 2 diabetic man of Korean ethnicity with fever, abdominal pain, and right eye visual disturbance.
    Pollett S; McMullan B; Lam VW; Qureshi C; Kok J
    Clin Infect Dis; 2015 Feb; 60(4):611; answer 664-5. PubMed ID: 25617417
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal abscess in a new born secondary to Klebsiella septicaemia--a case report.
    Kumari PG; Rao PL; Antony B; Shivananda PG
    Indian J Pathol Microbiol; 1998 Jan; 41(1):101-2. PubMed ID: 9581084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
    Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS
    J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Native valve postoperative Klebsiella pneumoniae endocarditis].
    Bellazreg F; Gaillet M; Perronne C; Crémieux AC
    Med Mal Infect; 2012 Feb; 42(2):85-6. PubMed ID: 22245523
    [No Abstract]   [Full Text] [Related]  

  • 14. TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report.
    Yu X; Pan J; Zhou Z; Wen X; Dai Y; Lin G; Jiao Z; Zhang C
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):201-204. PubMed ID: 32661810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors, Outcomes, and Mechanisms of Tigecycline-Nonsusceptible Klebsiella pneumoniae Bacteremia.
    Juan CH; Huang YW; Lin YT; Yang TC; Wang FD
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7357-7363. PubMed ID: 27697759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klebsiella pneumoniae bacteremia: community-acquired vs. nosocomial infections.
    Yang PY; Huang CC; Leu HS; Chiang PC; Wu TL; Tsao TC
    Chang Gung Med J; 2001 Nov; 24(11):688-96. PubMed ID: 11820649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Klebsiella endophthalmitis associated with pyogenic liver abscess.
    Yang CS; Tsai HY; Sung CS; Lin KH; Lee FL; Hsu WM
    Ophthalmology; 2007 May; 114(5):876-80. PubMed ID: 17467526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
    Chuang TY; Lin CJ; Chi CL; Liu AY; Lee SW; Lin TL; Wang JT; Hsueh PR
    J Microbiol Immunol Infect; 2009 Oct; 42(5):439-41. PubMed ID: 20182675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.